305 related articles for article (PubMed ID: 32636414)
1. Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras.
Perrot CY; Herrera JL; Fournier-Goss AE; Komatsu M
Sci Rep; 2020 Jul; 10(1):11186. PubMed ID: 32636414
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
Nasrallah R; Hassouneh R; Zimpelmann J; Karam AJ; Thibodeau JF; Burger D; Burns KD; Kennedy CR; Hébert RL
Lab Invest; 2015 Sep; 95(9):1044-55. PubMed ID: 26121313
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
4. CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4/AC/cAMP/PKA-mediated GRK2 translocation.
Han CC; Liu Q; Zhang Y; Li YF; Cui DQ; Luo TT; Zhang YW; Wang XM; Wang C; Ma Y; Wei W
Clin Sci (Lond); 2020 Feb; 134(3):331-347. PubMed ID: 31967309
[TBL] [Abstract][Full Text] [Related]
5. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
[TBL] [Abstract][Full Text] [Related]
7. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
[TBL] [Abstract][Full Text] [Related]
8. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
9. Vascular Pericyte Impairment and Connexin43 Gap Junction Deficit Contribute to Vasomotor Decline in Diabetic Retinopathy.
Ivanova E; Kovacs-Oller T; Sagdullaev BT
J Neurosci; 2017 Aug; 37(32):7580-7594. PubMed ID: 28674171
[TBL] [Abstract][Full Text] [Related]
10. R-Ras Deficiency in Pericytes Causes Frequent Microphthalmia and Perturbs Retinal Vascular Development.
Herrera JL; Komatsu M
J Vasc Res; 2021; 58(4):252-266. PubMed ID: 33873190
[TBL] [Abstract][Full Text] [Related]
11. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
12. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors.
St-Jacques B; Ma W
Exp Neurol; 2014 Nov; 261():354-66. PubMed ID: 24910202
[TBL] [Abstract][Full Text] [Related]
13. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
14. PGE
Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
[TBL] [Abstract][Full Text] [Related]
15. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts.
Rieder F; Georgieva M; Schirbel A; Artinger M; Zügner A; Blank M; Brenmoehl J; Schölmerich J; Rogler G
Inflamm Bowel Dis; 2010 Sep; 16(9):1505-13. PubMed ID: 20803697
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
[TBL] [Abstract][Full Text] [Related]
19. Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.
McGuire PG; Rangasamy S; Maestas J; Das A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e107-15. PubMed ID: 21940944
[TBL] [Abstract][Full Text] [Related]
20. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
